Omkar Speciality Chemicals files delayed quarterly results
The company released unaudited results for three quarters ending December 2025, confirming ongoing losses and negative net worth.
— 1 earlier story on Omkar Speciality Chemicals Ltd. →What's new
- Omkar Speciality Chemicals filed unaudited results for Q1, Q2, and Q3 of FY26.
- The filings confirm continued losses and negative net worth.
- Results include audit qualifications linked to the ongoing CIRP process.
Why this matters
These results are a procedural compliance update rather than a new market event. The NCLT approved the company's resolution plan in July 2025, and the financial distress reflected here is already known to the market.
What we're watching
- Progress on the implementation of the NCLT-approved resolution plan.
- Any further audit qualifications in the final annual report.
- Timeline for the company's exit from the CIRP process.
The full read
Omkar Speciality Chemicals just filed unaudited financial results for three quarters ending June 30, 2025, September 30, 2025, and December 31, 2025.
These documents confirm the company's ongoing financial distress, which is marked by persistent losses and a negative net worth position. Because the NCLT approved the company's resolution plan on July 31, 2025, these figures offer no new tradeable information to the market. The filing is a routine compliance exercise. The market has already priced in the insolvency status and the resolution plan. There is nothing here to change the current outlook.
Questions answered
- What periods do these financial results cover?
- The filing covers three quarterly periods: June 30, 2025, September 30, 2025, and December 31, 2025.
- Do these results contain new information for investors?
- No. The filing is a routine compliance update that confirms existing financial distress and audit qualifications already known to the market.
- What is the current status of the company's resolution process?
- The NCLT approved the company's resolution plan on July 31, 2025. This filing is a procedural step following that approval.
- What do the audit reports highlight?
- The limited review reports contain qualifications directly related to the ongoing Corporate Insolvency Resolution Process (CIRP).
Story so far
All notes on OMKARCHEM →- 29 May 2026 · 2:53 PM IST Omkar Speciality Chemicals files delayed quarterly results
- 1d ago Omkar Speciality Chemicals files routine quarterly results